EyeGene Inc (185490) — Financial Flexibility Index
EyeGene Inc (185490) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of ₩-328.75 Million (operating CF ₩-904.39 Million minus capex ₩575.64 Million) represents 0% of total liabilities (₩12.55 Billion). Also explore EyeGene Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
EyeGene Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for EyeGene Inc across 11 annual periods. Check EyeGene Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for EyeGene Inc (2014–2024)
Year-by-year free cash flow to debt coverage for EyeGene Inc. For the full company profile including market capitalisation, see EyeGene Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.48x | ₩-7.18 Billion | ₩-12.17 Billion | ₩14.98 Billion | ▲ +64.1% |
| 2023 | -1.34x | ₩-18.40 Billion | ₩-20.07 Billion | ₩13.77 Billion | ▼ -2.5% |
| 2022 | -1.30x | ₩-17.80 Billion | ₩-18.57 Billion | ₩13.65 Billion | ▲ +24.4% |
| 2021 | -1.72x | ₩-27.63 Billion | ₩-30.00 Billion | ₩16.02 Billion | ▼ -604.1% |
| 2020 | -0.24x | ₩-7.72 Billion | ₩-9.75 Billion | ₩31.53 Billion | ▲ +5.5% |
| 2019 | -0.26x | ₩-7.33 Billion | ₩-8.32 Billion | ₩28.28 Billion | ▼ -9.9% |
| 2018 | -0.24x | ₩-7.24 Billion | ₩-7.48 Billion | ₩30.70 Billion | ▲ +76.3% |
| 2017 | -0.99x | ₩-6.49 Billion | ₩-6.76 Billion | ₩6.53 Billion | ▲ +47.6% |
| 2016 | -1.90x | ₩-4.49 Billion | ₩-5.99 Billion | ₩2.37 Billion | ▲ +31.8% |
| 2015 | -2.78x | ₩-4.35 Billion | ₩-4.48 Billion | ₩1.57 Billion | ▼ -130.2% |
| 2014 | -1.21x | ₩-2.04 Billion | ₩-2.39 Billion | ₩1.69 Billion | — |